All entries for: Proalix BioTherapeutics

March 18, 2026

Proalix BioTherapeutics

Negative Outlook

Hackensack, NJ
1-50 employees

Limited reimbursement amounts may reduce the demand for, or the price of, Elfabrio, Elelyso or any other future products. If coverage and reimbursement are not available or are available only to limited levels, the sales of Elfabrio, Elelyso or other future products, if any, may be diminished or we may not be able to sell such products profitably.

Disease Area: Rare Diseases
Scroll to Top